A detailed history of True North Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, True North Advisors, LLC holds 5,502 shares of ABBV stock, worth $973,578. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,502
Previous 5,522 0.36%
Holding current value
$973,578
Previous $947,000 14.68%
% of portfolio
0.29%
Previous 0.25%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $3,276 - $3,986
-20 Reduced 0.36%
5,502 $1.09 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $171,352 - $200,101
-1,107 Reduced 16.7%
5,522 $947,000
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $18,858 - $21,487
118 Added 1.81%
6,629 $1.21 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $23,254 - $26,189
-169 Reduced 2.53%
6,511 $1.01 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $21,507 - $24,898
-161 Reduced 2.35%
6,680 $995,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $279,463 - $347,774
2,109 Added 44.57%
6,841 $921,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $61,603 - $70,946
426 Added 9.89%
4,732 $754,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $93,497 - $112,128
676 Added 18.62%
4,306 $696,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $45,899 - $52,644
-342 Reduced 8.61%
3,630 $487,000
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $546,626 - $694,941
3,972 New
3,972 $608,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $850,611 - $1.06 Million
-6,445 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $427,249 - $540,593
-3,977 Reduced 38.16%
6,445 $872,000
Q3 2021

Jun 07, 2022

BUY
$106.4 - $120.78 $296,430 - $336,493
2,786 Added 36.49%
10,422 $1.12 Million
Q2 2021

Jun 07, 2022

BUY
$105.21 - $117.21 $45,345 - $50,517
431 Added 5.98%
7,636 $860,000
Q1 2021

Jun 07, 2022

SELL
$102.3 - $112.62 $127,670 - $140,549
-1,248 Reduced 14.76%
7,205 $779,000
Q4 2020

May 20, 2022

BUY
$80.49 - $108.67 $79,765 - $107,691
991 Added 13.28%
8,453 $905,000
Q3 2020

May 20, 2022

BUY
$85.91 - $100.83 $13,573 - $15,931
158 Added 2.16%
7,462 $653,000
Q2 2020

May 20, 2022

BUY
$73.37 - $98.18 $308,520 - $412,846
4,205 Added 135.69%
7,304 $717,000
Q1 2020

May 12, 2022

BUY
$64.5 - $97.79 $1,161 - $1,760
18 Added 0.58%
3,099 $236,000
Q4 2019

May 12, 2022

BUY
$72.13 - $90.25 $222,232 - $278,060
3,081 New
3,081 $272,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track True North Advisors, LLC Portfolio

Follow True North Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.